NOXXON Pharma today announced the treatment of the first cohort of three chronic lymphocytic leukemia (CLL) patients in a Phase IIa clinical trial of its...
What is exome sequencing? Leah Eisenstadt, October 15th, 2010| Filed under Word of the day "The human genome consists of 3 billion nucleotides or "letters" of...
Greetings, Here's a selection from latest posts made to PAL's facebook page http://www.facebook.com/lymphomation.PAL You can visit and then "LIKE" us to...
Cell. 2011 Mar 4;144(5):646-74. Hallmarks of cancer: the next generation. http://1.usa.gov/OoTGsl This report has added emerging hallmarks: 1) reprogramming of...
Nice celebrity video on this page. One in two men and one in three women in the U.S. are expected to be diagnosed with cancer in their lifetimes, and almost...
Regarding the use of PET imaging for lymphoma in the different circumstances, Dr. Rebecca Elstrom kindly shared her perspective: "I suspect you will get...
BlankPhase IIa of anti-CXCL12/SDF-1 Spiegelmer® NOX-A12 for Treatment of CLL July 11, 2012 09:03 AM Eastern Daylight Time BERLIN--(BUSINESS WIRE)--NOXXON...
Stephen Schneider is a survivor of MCL ... and also a professor at Stanford, and senior fellow at the Woods Institute for the Environment. In his talk on ...
Greetings, There is growing excitement about the potential of a new class of agents that targets immune checkpoints (such as PD-1 antibody), which is showing ...
Perhaps a study to inquire about if seemingly out of options. 3-AP (Triapine) and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma...
BlankNew Target Found Deep Within Cancer Cells 11 Jul 2012 Investigators reporting in the July issue of the Cell Press journal Cancer Cell have found that...
Questions for your doctor ... a checklist http://www.lymphomation.org/images/questions.pdf Feel free to print and distribute, if you find it useful that is....
Interesting post from the New Yorker. Mentions the CAR-T therapy for CLL. http://www.newyorker.com/reporting/2012/04/23/120423fa_fact_groopman?currentPage=all...
Collaborating to Conquer Cancer: Lessons from Our Children-Presidential Address of Michael P. Link, MD Watch a video of Dr. Link delivering his speech or read...
Late Onset Neutropenia (LON) following Rituxan therapy - incidence, risk factors, and possible mechanisms http://www.medscape.com/viewarticle/754000 "the...
Tumor cells' inner workings predict cancer progression Email this article Date: 2012-07-27 Phone: (619) 543-6163 Email: slafee@... SAN DIEGO — Using a...
For some reason ABT-199, a new improved version of ABT-263 which had platelet problems, is not on your list. A recent development maybe but worth noting. ...
Greetings, I'm very excited to begin to report on two recent experiences as a patient research advocate. One purpose is to help future research advocates;...
Novartis to partner with U Penn in developing CAR T-cell treatment, see http://pharmalive.com/news/index.cfm?articleID=851821&categoryid=9&newsletter=1 This...
Cancer Res. 2012 Jul 30. Markers of B-Cell Activation in Relation to Risk of Non-Hodgkin Lymphoma. De Roos Abstract B-cell activation biomarkers have been...
Dr. Sharman's CLL & Lymphoma Blog: How I approach follicular lymphoma (part 1) - patients with low risk disease http://bit.ly/T0OZtV (part 2) - and patients...
Steven P. Stratton, Ph.D.: "What is a drug? Any compound that alters a normal physiologic process. Pharmacokinetics (PK) is the mathematical study of drug...
Official Title: A Genetic Risk-Stratified, Randomized Phase II Study of Four Fludarabine/Antibody Combinations for Patients With Symptomatic, Previously ...
From Communicating Risks and Benefits An Evidence-Based User's guide - PDF http://1.usa.gov/PJog0g "Organizations bear economic, legal, and ethical obligations...
Apoptosis and necrosis are two major processes by which cells die. ... It is the ordered disassembly of the cell from within. It is a natural mechanism by...
Ublituximab NCI definition: "A chimeric recombinant IgG1 monoclonal antibody directed against human CD20 with potential antineoplastic activity. Ublituximab...
Chemotherapy can have a vaccine effect ... when the tumor cells, killed by treatment, release antigen (abnormal proteins), which are evaluated by the immune...
